Patents Assigned to ARIZ Precision Medicine, Inc.
  • Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein
    Patent number: 12012597
    Abstract: Inhibitory RNA molecules that specifically inhibit mammalian RIZ2 expression, with therapeutic effect in cell proliferative diseases, such as cancer.
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: June 18, 2024
    Assignee: ARIZ Precision Medicine, Inc.
    Inventors: Lonnie L. Bookbinder, Narendra K. Vaish, Brad J. Niles, Jonathan Flynn, Nicole Nunez